denali therapeutics stock price today
View the latest Denali Therapeutics Inc. The low in the last 52 weeks of Denali Therapeutics stock was 2031.
Denali Therapeutics Inc Nasdaq Dnli Director Sells 616 400 00 In Stock Marketbeat
Denali Therapeutics DNLI stock price charts trades the USs most popular discussion forums.
. View real-time DNLI stock price and news along with industry-best analysis. According to the current price Denali Therapeutics is 13683 away from the 52-week low. SOUTH SAN FRANCISCO Calif Oct.
Stock information by Barrons. Latest stock price today and the USs most active stock market forums. The companys 50 day moving average price is 2981 and its two-hundred day.
DNLI Denali Therapeutics Inc Stock Price and Discussion Stocktwits. NASDAQDNLI Receives 7988 Average PT from Analysts. Following the completion of the sale the insider.
Denali Therapeutics Announces Pricing of 275 Million Public Offering of Common Stock. It enacted a public offering where it sold a total of 11933962 shares of its common stock at a price of. SOUTH SAN FRANCISCO Calif Oct.
19 2022 GLOBE NEWSWIRE -- Denali. Get the latest Denali Therapeutics Inc DNLI real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. Denali Therapeutics Stock Up 66.
The stock was sold at an average price of 3322 for a total transaction of 8557472. A high-level overview of Denali Therapeutics Inc. Shares of NASDAQDNLI opened at 2962 on Monday.
Price as of October 28 2022 400 pm. Find real-time DNLI - Denali Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. What was the 52-week high.
Denali Therapeutics is a great speculative biotech play to look into. Get Denali Therapeutics Inc DNLINASDAQ real-time stock quotes news price and financial information from CNBC. Not an offer or recommendation by Stocktwits.
Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Complete Denali Therapeutics Inc. Get the latest Denali Therapeutics Inc DNLI detailed stock quotes stock data Real-Time ECN charts stats.
In other Denali Therapeutics news. DNLI today announced the closing of its upsized underwritten. Denali Therapeutics proposes 250M stock offering.
Denali Therapeutics DNLI has priced its underwritten public offering of 10377359 shares of its common stock at a price to the public of 2650shareAll of the shares are to be. Shares down 6 post. Youre reading a free stock page from The Motley Fools Premium Investing Services.
View Denali Therapeutics Inc DNLI investment stock information. Common Stock DNLI Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. 24 2022 GLOBE NEWSWIRE -- Denali Therapeutics Inc.
Denali Therapeutics Inc NASDAQ. Denali Therapeutics Announces Pricing of 275 Million Public Offering of Common Stock. DNLI stock price news historical charts analyst ratings and financial information from WSJ.
Denali Therapeutics Celebrates Its Ipo At The Nasdaq Marketsite
Denali Therapeutics Crunchbase Company Profile Funding
As Denali Therapeutics Inc S Nasdaq Dnli Market Cap Dropped By Us 236m Insiders Who Sold Us 6 0m Worth Of Stock Were Able To Offset Their Losses Nasdaq
Denali Therapeutics Inc Statement Of Changes In Beneficial Ownership Form 4 Moneycontroller Id 718450
Denali Drops 7 In After Market On Halt Of Dnl747 Drug Study
Is Denali Therapeutics Inc Dnli Stock Rising Now
Denali Therapeutics Inc
As One Hopeful Alzheimer S Als Drug Fizzles Denali Brings Up A Second San Francisco Business Times
Is Denali Therapeutics A Solid Long Term Investment
Dnli Denali Therapeutics Full Company Report Zacks Com
Denali Inks Collab With Takeda To Help Alzheimer S Drugs Get Into The Brain Drug Delivery Business
Biogen And Denali Therapeutics Announce Initiation Of The Phase 3 Lighthouse Study In Parkinson S Disease Associated With Lrrk2 Pathogenic Mutations Biogen
Baillie Gifford Co Increases Ownership In Dnli Denali Therapeutics Inc
Denali Therapeutics Stock Nasdaq Dnli Quotes And News Summary Benzinga
Potential 2 4 Billion Denali Biogen Deal Targets Parkinson S Alzheimer S Ms And More San Francisco Business Times
We Think Denali Therapeutics Nasdaq Dnli Can Afford To Drive Business Growth Nasdaq
Denali Pharma Stock Price Stock Trading Courses Miami
Will Denali Therapeutics Inc Dnli Report Negative Q2 Earnings What You Should Know
Denali Therapeutics Inc Nasdaq Dnli Analysts Are Reducing Their Forecasts For This Year